SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-022819
Filing Date
2022-11-08
Accepted
2022-11-07 21:12:21
Documents
14
Period of Report
2022-11-07
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K dnay-20221107.htm   iXBRL 8-K 59931
2 EX-3.1 dnay-ex3_1.htm EX-3.1 10891
3 EX-3.2 dnay-ex3_2.htm EX-3.2 327265
  Complete submission text file 0000950170-22-022819.txt   562610

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dnay-20221107_lab.xml EX-101.LAB 14449
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dnay-20221107.xsd EX-101.SCH 2462
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dnay-20221107_pre.xml EX-101.PRE 11809
8 EXTRACTED XBRL INSTANCE DOCUMENT dnay-20221107_htm.xml XML 5063
Mailing Address 9535 WAPLES STREET SUITE 100 SAN DIEGO CA 92121
Business Address 9535 WAPLES STREET SUITE 100 SAN DIEGO CA 92121 858-228-4115
Telesis Bio Inc. (Filer) CIK: 0001850079 (see all company filings)

IRS No.: 451216839 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40497 | Film No.: 221366955
SIC: 3826 Laboratory Analytical Instruments